Bipartisan Senate Bill Aims To Hasten Key Drug Approvals
Three U.S. senators introduced a bipartisan bill Monday that would expedite U.S. Food and Drug Administration drug approvals if a treatment showed great promise early on in its testing....To view the full article, register now.
Already a subscriber? Click here to view full article